NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells. Guan L, Nambiar DK, Cao H, Viswanathan V, et al. Cancer Res 2023 Jan 19:CAN-22-1903. doi: 10.1158/0008-5472.CAN-22-1903.

Read + Share

Amedeo Smart

Independent Medical Education

Guan L, Nambiar DK, Cao H, Viswanathan V, et al. NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells. Cancer Res 2023 Jan 19:CAN-22-1903. doi: 10.1158/0008-5472.CAN-22-1903.
PMID: 36652552